Page last updated: 2024-10-21

1-anilino-8-naphthalenesulfonate and Arthritis, Rheumatoid

1-anilino-8-naphthalenesulfonate has been researched along with Arthritis, Rheumatoid in 2 studies

1-anilino-8-naphthalenesulfonate: RN given refers to parent cpd
8-anilinonaphthalene-1-sulfonic acid : A naphthalenesulfonic acid that is naphthalene-1-sulfonic acid substituted by a phenylamino group at position 8.

Arthritis, Rheumatoid: A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhou, HF1
Yan, H1
Senpan, A1
Wickline, SA1
Pan, D1
Lanza, GM1
Pham, CT1
Jacobs, JW1
Rasker, JJ1
van Riel, PL1
Gribnau, FW1
van de Putte, LB1

Trials

1 trial available for 1-anilino-8-naphthalenesulfonate and Arthritis, Rheumatoid

ArticleYear
Rheumajecta and vasolastine in the treatment of rheumatoid arthritis--the results of a placebo-controlled, double-blind trial of a complementary treatment.
    Scandinavian journal of rheumatology, 1991, Volume: 20, Issue:6

    Topics: Adolescent; Adult; Aged; Arthritis, Rheumatoid; Catalase; Choline O-Acetyltransferase; Double-Blind

1991

Other Studies

1 other study available for 1-anilino-8-naphthalenesulfonate and Arthritis, Rheumatoid

ArticleYear
Suppression of inflammation in a mouse model of rheumatoid arthritis using targeted lipase-labile fumagillin prodrug nanoparticles.
    Biomaterials, 2012, Volume: 33, Issue:33

    Topics: Animals; Arthritis, Rheumatoid; Cyclohexanes; Electrophoresis; Enzyme-Linked Immunosorbent Assay; Fa

2012